Cardiovascular disease – the silent killer in rheumatoid arthritis
Namita Kumar and David J Armstrong
DOI: https://doi.org/10.7861/clinmedicine.8-4-384
Clin Med August 2008 Namita Kumar
University Hospital of North Durham, Durham
MBChB MMEd MRCPRoles: Consultant Physician and Rheumatologist
David J Armstrong
University Hospital of North Durham, Durham
MD MRCP FRCPIRoles: Consultant Rheumatologist
Abstract
Rheumatoid arthritis (RA) is a multi-system disease with high rates of morbidity and mortality. In recent years, there has been increasing focus on the growing rates of cardiovascular disease (CVD) in RA, over and above expected levels allowing for ‘traditional’ risk factors. In this paper the impact of CVD in RA, the relative contributions of traditional risk factors and novel risk factors (including homocysteine, oxidised low-density lipoprotein, high-sensitivity C-reactive protein and leptin), and the need to address cardiovascular risk in the fight against premature death from coronary artery and stroke disease in RA are discussed.
- C-reactive protein
- cardiovascular disease
- coronary artery disease
- homocysteine
- hyperlipidaemia
- hypertension
- rheumatoid arthritis
- © 2008 Royal College of Physicians
Article Tools
Cardiovascular disease – the silent killer in rheumatoid arthritis
Namita Kumar, David J Armstrong
Clinical Medicine Aug 2008, 8 (4) 384-387; DOI: 10.7861/clinmedicine.8-4-384
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.